Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-114293
Filing Date
2025-09-11
Accepted
2025-09-11 17:20:43
Documents
1
Period of Report
2025-09-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7075
  Complete submission text file 0000950170-25-114293.txt   8605
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address
Savitz Ryan (Reporting) CIK: 0001992324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 251309335